PL03.03. First-line Amivantamab-chemotherapy vs Chemotherapy in NSCLC with EGFR Exon 20 Insertions: Overall Survival from PAPILLON

Monday, September 14, 2026 8:49 AM to 8:59 AM · 10 min. (Asia/Seoul)

Join the event!

See all the content and easy-to-use features by logging in or registering!